{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:53:05Z","timestamp":1793141585819,"version":"4.5.0"},"reference-count":94,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Investigational Drugs"],"published-print":{"date-parts":[[2026,5,4]]},"DOI":"10.1080\/13543784.2026.2676066","type":"journal-article","created":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:47:44Z","timestamp":1779115664000},"page":"329-339","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":2,"title":["New insights into the management of Beh\u00e7et syndrome"],"prefix":"10.1080","volume":"35","author":[{"given":"Sinem Nihal","family":"Esatoglu","sequence":"first","affiliation":[{"name":"Istanbul University-Cerrahpa\u015fa","place":["Istanbul, T\u00fcrkiye"]},{"name":"Istanbul University-Cerrahpa\u015fa","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yesim","family":"Ozguler","sequence":"additional","affiliation":[{"name":"Istanbul University-Cerrahpa\u015fa","place":["Istanbul, T\u00fcrkiye"]},{"name":"Istanbul University-Cerrahpa\u015fa","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulen","family":"Hatemi","sequence":"additional","affiliation":[{"name":"Istanbul University-Cerrahpa\u015fa","place":["Istanbul, T\u00fcrkiye"]},{"name":"Istanbul University-Cerrahpa\u015fa","place":["Istanbul, T\u00fcrkiye"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,5,18]]},"reference":[{"key":"e_1_3_5_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2023.03.010"},{"key":"e_1_3_5_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(23)02629-6"},{"key":"e_1_3_5_5_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-200301000-00006"},{"key":"e_1_3_5_6_1","doi-asserted-by":"publisher","DOI":"10.2147\/JMDH.S93681"},{"key":"e_1_3_5_7_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2305712"},{"key":"e_1_3_5_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213225"},{"key":"e_1_3_5_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.rdc.2017.09.007"},{"key":"e_1_3_5_10_1","doi-asserted-by":"publisher","DOI":"10.4103\/sjopt.sjopt_228_24"},{"key":"e_1_3_5_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-022-00880-7"},{"key":"e_1_3_5_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrrheum.2018.3"},{"key":"e_1_3_5_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2016.08.002"},{"key":"e_1_3_5_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2026.02.009"},{"key":"e_1_3_5_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ero.2026.02.017"},{"key":"e_1_3_5_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ero.2026.02.019"},{"key":"e_1_3_5_17_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220317"},{"key":"e_1_3_5_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.41026"},{"key":"e_1_3_5_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2022.02.002"},{"key":"e_1_3_5_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4228-6"},{"key":"e_1_3_5_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4069-3"},{"key":"e_1_3_5_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39667"},{"key":"e_1_3_5_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab944"},{"key":"e_1_3_5_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae416"},{"key":"e_1_3_5_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard-2024-226113"},{"key":"e_1_3_5_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)05497-6"},{"key":"e_1_3_5_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1509852"},{"key":"e_1_3_5_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.05.027"},{"key":"e_1_3_5_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/33.1.48"},{"key":"e_1_3_5_30_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kez598"},{"key":"e_1_3_5_31_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300354"},{"key":"e_1_3_5_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40531"},{"key":"e_1_3_5_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.13778"},{"key":"e_1_3_5_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/1708538120927701"},{"key":"e_1_3_5_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2015.06.008"},{"key":"e_1_3_5_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109682"},{"key":"e_1_3_5_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2018.08.004"},{"key":"e_1_3_5_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000003550"},{"key":"e_1_3_5_39_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/5lnkd4"},{"key":"e_1_3_5_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/1756-185X.14209"},{"key":"e_1_3_5_41_1","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000258"},{"key":"e_1_3_5_42_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-024-07118-9"},{"key":"e_1_3_5_43_1","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.1969-23"},{"key":"e_1_3_5_44_1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318242ff37"},{"key":"e_1_3_5_45_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408684"},{"key":"e_1_3_5_46_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1816594"},{"key":"e_1_3_5_47_1","doi-asserted-by":"publisher","DOI":"10.1093\/mr\/roab098"},{"key":"e_1_3_5_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keae274"},{"issue":"1","key":"e_1_3_5_49_1","first-page":"98","article-title":"Short-term trial of etanercept in Behcet\u2019s disease: a double blind, placebo controlled study","volume":"32","author":"Melikoglu M","year":"2005","unstructured":"Melikoglu M, Fresko I, Mat C, et al. Short-term trial of etanercept in Behcet\u2019s disease: a double blind, placebo controlled study. J Rheumatol. 2005;32(1):98\u2013105.","journal-title":"J Rheumatol"},{"key":"e_1_3_5_50_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002013220501"},{"key":"e_1_3_5_51_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keag010"},{"issue":"6","key":"e_1_3_5_52_1","first-page":"43","article-title":"Adalimumab provides long-lasting clinical improvement in refractory mucocutaneous Beh\u00e7et\u2019s disease without formation of antidrug antibodies","volume":"37","author":"Verboom DM","year":"2019","unstructured":"Verboom DM, van der Houwen TB, Kappen JH, et al. Adalimumab provides long-lasting clinical improvement in refractory mucocutaneous Beh\u00e7et\u2019s disease without formation of antidrug antibodies. Clin Exp Rheumatol. 2019;37 Suppl 121(6):43\u201347.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_53_1","doi-asserted-by":"publisher","DOI":"10.1186\/1546-0096-13-S1-P166"},{"key":"e_1_3_5_54_1","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.618973"},{"key":"e_1_3_5_55_1","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1095423"},{"key":"e_1_3_5_56_1","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-018-1793-7"},{"key":"e_1_3_5_57_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-018-4092-4"},{"key":"e_1_3_5_58_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40235"},{"key":"e_1_3_5_59_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-025-05806-6"},{"key":"e_1_3_5_60_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.040"},{"key":"e_1_3_5_61_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217108"},{"key":"e_1_3_5_62_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2018.09.002"},{"key":"e_1_3_5_63_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.25259\/IJDVL_1883_2024","article-title":"Secukinumab induced paradoxical worsening of mucocutaneous features of Behcet\u2019s disease","volume":"12","author":"Goyal A","year":"2025","unstructured":"Goyal A, Meshram AS, Gupta V. Secukinumab induced paradoxical worsening of mucocutaneous features of Behcet\u2019s disease. Indian J Dermatol Venereol Leprol. 2025;12:1\u20133.","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"e_1_3_5_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2024.2347440"},{"key":"e_1_3_5_65_1","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2023.2235040"},{"key":"e_1_3_5_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14196"},{"key":"e_1_3_5_67_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16454"},{"key":"e_1_3_5_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/omcr\/omz041"},{"key":"e_1_3_5_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2021.11.045"},{"key":"e_1_3_5_70_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.40912"},{"issue":"6","key":"e_1_3_5_71_1","first-page":"130","article-title":"Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behcet\u2019s disease","volume":"35","author":"Lopalco G","year":"2017","unstructured":"Lopalco G, Fabiani C, Venerito V, et al. Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behcet\u2019s disease. Clin Exp Rheumatol. 2017;35(6):130\u2013131.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-019-04259-y"},{"key":"e_1_3_5_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2017.1421233"},{"key":"e_1_3_5_74_1","doi-asserted-by":"publisher","DOI":"10.3109\/09273948.2015.1092558"},{"key":"e_1_3_5_75_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-155143"},{"key":"e_1_3_5_76_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2022.152153"},{"issue":"8","key":"e_1_3_5_77_1","first-page":"1575","article-title":"IL-6 blockade for Behcet\u2019s disease: review on 31 anti-TNF naive and 45 anti-TNF experienced patients","volume":"40","author":"Arida A","year":"2022","unstructured":"Arida A, Saadoun D, Sfikakis PP. IL-6 blockade for Behcet\u2019s disease: review on 31 anti-TNF naive and 45 anti-TNF experienced patients. Clin Exp Rheumatol. 2022;40(8):1575\u20131583.","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_3_5_78_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2025.1694311"},{"key":"e_1_3_5_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.03.006"},{"key":"e_1_3_5_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2589-z"},{"key":"e_1_3_5_81_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket130"},{"key":"e_1_3_5_82_1","doi-asserted-by":"publisher","DOI":"10.55563\/clinexprheumatol\/3myixe"},{"issue":"2","key":"e_1_3_5_83_1","first-page":"e1","article-title":"Use of upadacitinib in refractory Behcet\u2019s disease: case report and systematic literature review","volume":"24","author":"Patel A","year":"2025","unstructured":"Patel A, Guenin S, Amara S, et al. Use of upadacitinib in refractory Behcet\u2019s disease: case report and systematic literature review. J Drugs Dermatol. 2025;24(2):e1\u2013e6.","journal-title":"J Drugs Dermatol"},{"key":"e_1_3_5_84_1","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2023.2263557"},{"key":"e_1_3_5_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109298"},{"key":"e_1_3_5_86_1","doi-asserted-by":"publisher","DOI":"10.1177\/1759720X221124014"},{"key":"e_1_3_5_87_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217307"},{"issue":"9","key":"e_1_3_5_88_1","article-title":"Efficacy and safety of jak inhibitors in Beh\u00e7et\u2019s syndrome: a systematic literature review [abstract]","volume":"77","author":"Sulu B ES","year":"2025","unstructured":"Sulu B ES, Hatemi I, Celik A, et al. Efficacy and safety of jak inhibitors in Beh\u00e7et\u2019s syndrome: a systematic literature review [abstract]. Arthritis Rheumatol. 2025;77(9). [cited 2026 Feb 25] Available from: https:\/\/acrabstracts.org\/abstract\/efficacy-and-safety-of-jak-inhibitors-in-behcets-syndrome-a-systematic-literature-review\/","journal-title":"Arthritis Rheumatol"},{"key":"e_1_3_5_89_1","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llae284"},{"key":"e_1_3_5_90_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.17972"},{"key":"e_1_3_5_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ard.2026.01.014"},{"key":"e_1_3_5_92_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaf682"},{"key":"e_1_3_5_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(89)92381-7"},{"issue":"4","key":"e_1_3_5_94_1","first-page":"S84","article-title":"Cyclosporine for Beh\u00e7et\u2019s uveitis: is it associated with an increased risk of neurological involvement?","volume":"26","author":"Akman-Demir G","year":"2008","unstructured":"Akman-Demir G, Ayranci O, Kurtuncu M, et al. Cyclosporine for Beh\u00e7et\u2019s uveitis: is it associated with an increased risk of neurological involvement? Clin Exp Rheumatol. 2008;26(4 Suppl 50):S84\u201390.","journal-title":"Clin Exp Rheumatol"},{"issue":"4","key":"e_1_3_5_95_1","first-page":"148","article-title":"Long-term effects of cyclophosphamide and colchicine treatment in Behcet\u2019s disease","volume":"23","author":"Kazokoglu H","year":"1991","unstructured":"Kazokoglu H, Saatci O, Cuhadaroglu H, et al. Long-term effects of cyclophosphamide and colchicine treatment in Behcet\u2019s disease. Ann Ophthalmol. 1991;23(4):148\u2013151.","journal-title":"Ann Ophthalmol"},{"key":"e_1_3_5_96_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1803537"}],"container-title":["Expert Opinion on Investigational Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/13543784.2026.2676066","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T06:51:10Z","timestamp":1779951070000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/13543784.2026.2676066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,4]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5,4]]}},"alternative-id":["10.1080\/13543784.2026.2676066"],"URL":"https:\/\/doi.org\/10.1080\/13543784.2026.2676066","relation":{},"ISSN":["1354-3784","1744-7658"],"issn-type":[{"value":"1354-3784","type":"print"},{"value":"1744-7658","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,4]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ieid20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2026-03-10","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-14","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}